共 25 条
Synthesis and Anti-Inflammatory Evaluation of Novel C66 Analogs for the Treatment of LPS-Induced Acute Lung Injury
被引:11
作者:
Feng, Jianpeng
[1
]
Xiao, Bing
[1
]
Chen, Wenbo
[1
]
Ding, Ting
[2
]
Chen, Lingfeng
[1
]
Yu, Pengtian
[1
]
Xu, Fengli
[3
]
Zhang, Huajie
[1
]
Liu, Zhiguo
[1
]
Liang, Guang
[1
]
机构:
[1] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Lishui Peoples Hosp, Translat Med Res Ctr, Lishui 323000, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Affiliated Hosp 2, Dept Paediat, Wenzhou 325000, Zhejiang, Peoples R China
关键词:
acute lung injury;
C66;
chemical stability;
drug design;
synthesis;
NF-KAPPA-B;
MONO-CARBONYL ANALOGS;
MONOCARBONYL ANALOGS;
DIABETIC-RATS;
CURCUMIN;
ANTIOXIDANT;
INHIBITION;
DISEASES;
MICE;
D O I:
10.1111/cbdd.12548
中图分类号:
Q5 [生物化学];
Q7 [分子生物学];
学科分类号:
071010 ;
081704 ;
摘要:
We previously reported a symmetric monocarbonyl analog of curcumin (MACs), C66, which demonstrated potential anti-inflammatory activity and low toxicity. In continuation of our ongoing research, we designed and synthesized 34 asymmetric MACs based on C66 as a lead molecule. A majority of the C66 analogs effectively inhibited LPS induction of TNF- and IL-6 expression. Additionally, a preliminary SAR was conducted. Furthermore, active compounds 4a11 and 4a16 were found to effectively reduce theW/D ratio in the lungs and the protein concentration in the bronchoalveolar lavage fluid (BALF). Meanwhile, a histopathological examination indicated that these two analogs significantly attenuate tissue injury in the lungs with LPS-induced ALI rats. 4a11 and 4a16 also inhibited mRNA expression of several inflammatory cytokines, including TNF-, IL-6, IL-1, COX-2, ICAM-1 and VCAM-1, in the Beas-2B cellsafter LPS challenge. Altogether, the data exhibit a series of new C66 analogs as promising anti-inflammatory agents for the treatment of LPS-induced ALI.
引用
收藏
页码:753 / 763
页数:11
相关论文